Wall Street Titan's Small Cap Investor

On March 8th I discussed Athersys (ATHX) and its seemingly unreasonable valuation disparity in comparison to Australian stem cell company,...

As followers of this blog KNOW, I have been positive on the long term prospects of Cytori Therapeutics (CYTX) for some time and have writ...

Cytori Therapeutic today announced a strategic equity deal with Astellas Pharma, a leading Japanese Pharmacuetical company with over $11.8 b...

It's been a while since I've provided an update on Cytori Therapeutics even though there has been great news coming out over the l...

Today, Cytori Therapeutics expanded its Celution® System CE Mark and received additional indications-for-use for: Breast reconstruction; Re...

Acknowledging that the cellulosic ethanol business is a capital intensive industry requiring deep pockets that it didn't have, Verenium ...

As Cytori followers painfully know, Cytori's share price took a big hit when the FDA determined that its Celution technology would nee...

Yesterday, Cytori Therapeutics announced it had secured a $20,0000,000 secured loan facility from a group led by GE Capital. The loan has...

Merge Health Care (MRGE $2.35) is a small cap health care technology company that according to its website: ...develops solutions that autom...

Last week, in a ruling with great implications for the biotech industry. the District Court for the Southern District of New York ruled tha...

After reporting earnings on March 12th, shares of Cytori Therapeutic have been hit hard. Shares have fallen from $7.50 to below $5. The imp...

In a replay of the news from March 1, 2010 , Verenium and BP extended their Joint Development and License Agreement for one additional mont...

Today's Wall Street Journal has a very interesting and relevant article to the long term prospects of China Green Agriculture ( CGA $1...

Verenium an BP , whose 18 month cellulosic ethanol joint development agreement signed in August 2008 was set to expire, extended the agree...

Those who have followed Sirtuin Investor understand that one of the key aspects that make Cytori Therapeutics a compelling investment, aside...

Since the inception of the Sirtuin Investor on December 1, 2007, only a select handful of stocks have been profiled. Within a year of their...

A picture is worth 1,000 words: The face of a 55 year old office manager before a stem cell enhanced face lift performed by Dr. Aamer Khan ...

Those who had the opportunity to see any part of the 2008 Beijing Olympics, observed the sophistication of the world's most populous cou...

Here are the links to the Posters that were presented at the San Antonio Breast Cancer Symposium on Saturday December 12th by Cytori Therape...

Today, Cytori Therapeutics released the 6 month interim Clinical Phase II results of one of the many potential applications of its Celution...

Ever since the onset of the financial crisis, it has been in the back of my mind that there will come a time when it will make sense to put ...